Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,147 | -510 | -68,088 | -150,045 | -174,370 |
| Depreciation Amortization | 14,526 | 7,689 | 35,383 | 30,487 | 23,154 |
| Accounts receivable | -4,749 | 21,623 | -29,789 | 61,232 | 37,040 |
| Accounts payable and accrued liabilities | 39,632 | 16,371 | 11,035 | -1,196 | -1,925 |
| Other Working Capital | -18,084 | 8,288 | -33,127 | 25,969 | 11,882 |
| Other Operating Activity | 31,175 | -20,585 | 167,741 | 71,928 | 80,169 |
| Operating Cash Flow | $61,353 | $32,876 | $83,155 | $38,375 | $-24,050 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -100,117 | N/A | N/A | N/A | N/A |
| PPE Investments | -32,417 | -10,342 | -16,260 | -11,170 | -4,075 |
| Investing Cash Flow | $-132,534 | $-10,342 | $-16,260 | $-11,170 | $-4,075 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 393,500 | N/A | 27,865 | 27,865 | 27,865 |
| Debt Repayment | -406,389 | -40 | -106 | -67 | -44 |
| Common Stock Issued | 4,598 | 920 | 546,366 | 542,504 | 541,353 |
| Common Stock Repurchased | -21,361 | N/A | -113 | -22 | -22 |
| Other Financing Activity | -6,427 | -56 | 90,977 | 91,310 | 113,535 |
| Financing Cash Flow | $-36,079 | $824 | $664,989 | $661,590 | $682,687 |
| Exchange Rate Effect | -37 | -10 | 130 | 159 | 97 |
| Beginning Cash Position | 800,042 | 800,042 | 68,028 | 68,028 | 68,028 |
| End Cash Position | 692,745 | 823,390 | 800,042 | 756,982 | 722,687 |
| Net Cash Flow | $-107,297 | $23,348 | $732,014 | $688,954 | $654,659 |
| Free Cash Flow | |||||
| Operating Cash Flow | 61,353 | 32,876 | 83,155 | 38,375 | -24,050 |
| Capital Expenditure | -32,417 | -10,342 | -16,260 | -11,170 | -4,075 |
| Free Cash Flow | 28,936 | 22,534 | 66,895 | 27,205 | -28,125 |